We are live on
!
Find out more
APC
Alpine Peaks Capital Portfolio holdings
AUM
$85.4M
1-Year Est. Return
11.24%
This Fund
S&P 500
This Quarter
Est. Return
+7.81%
1 Year Est. Return
+11.24%
3 Year Est. Return
+24.3%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$124M
AUM Growth
+$12.1M
(+11%)
Cap. Flow
+$3.42M
Cap. Flow
% of AUM
2.77%
Top 10 Holdings %
Top 10 Hldgs %
55.42%
Holding
25
New
2
Increased
13
Reduced
10
Closed
–
Avg Time Held
3.6
quarters
Top 10 Avg Time Held
2.6
quarters
Top 20 Avg Time Held
3.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Maravai LifeSciences
MRVI
|
+$2.86M |
| 2 |
Evertec
EVTC
|
+$1.64M |
| 3 |
Robert Half
RHI
|
+$1.38M |
| 4 |
Qualys
QLYS
|
+$1.37M |
| 5 |
Rollins
ROL
|
+$1.19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IAA
IAA, Inc. Common Stock
IAA
|
+$3.43M |
| 2 |
Lindsay Corp
LNN
|
+$1.64M |
| 3 |
Interparfums
IPAR
|
+$1.34M |
| 4 |
Medpace
MEDP
|
+$1.13M |
| 5 |
Resources Connection
RGP
|
+$757K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 28.54% |
| 2 | Technology | 24.92% |
| 3 | Healthcare | 22.79% |
| 4 | Consumer Discretionary | 16.72% |
| 5 | Consumer Staples | 7.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Interparfums
IPAR
$3.58B
| $8.69M | 7.03% |
90,039
-15,450
| -15% | -$1.34M |
2021 Q4
4 quarters
|
|
2
Cognex
CGNX
$10.6B
| $7.72M | 6.25% |
163,895
+18,030
| +12% | +$845K |
2021 Q4
4 quarters
|
|
3
Wabtec
WAB
$48.4B
| $7.01M | 5.67% |
70,200
-975
| -1% | -$93.2K |
2021 Q4
4 quarters
|
|
|
4
Medpace
MEDP
$17.2B
| $7M | 5.67% |
32,951
-5,635
| -15% | -$1.13M |
2021 Q4
4 quarters
|
|
5
West Pharmaceutical
WST
$25.9B
| $6.85M | 5.54% |
29,102
+2,535
| +10% | +$601K |
2021 Q4
4 quarters
|
|
6
Service Corp International
SCI
$10.6B
| $6.58M | 5.32% |
95,121
-175
| -0.2% | -$11.7K |
2021 Q4
4 quarters
|
|
|
7
Rollins
ROL
$15.4B
| $6.24M | 5.05% |
170,879
+30,609
| +22% | +$1.19M |
2022 Q1
3 quarters
|
|
8
Trimble
TRMB
$13.9B
| $6.17M | 5% |
122,066
+10,300
| +9% | +$573K |
2021 Q4
4 quarters
|
|
9
US Physical Therapy
USPH
$1.27B
| $6.17M | 4.99% |
76,137
+2,890
| +4% | +$242K |
2021 Q4
4 quarters
|
|
|
10
Evertec
EVTC
$1.77B
| $6.04M | 4.89% |
186,493
+49,778
| +36% | +$1.64M |
2021 Q4
4 quarters
|
|
11
Bright Horizons
BFAM
$3.35B
| $5.64M | 4.57% |
89,396
-3,900
| -4% | -$255K |
2021 Q4
4 quarters
|
|
|
12
Qualys
QLYS
$6.95B
| $5.52M | 4.47% |
49,220
+11,005
| +29% | +$1.37M |
2021 Q4
4 quarters
|
|
|
13
Robert Half
RHI
$3.49B
| $5.39M | 4.36% |
73,011
+18,085
| +33% | +$1.38M |
2021 Q4
4 quarters
|
|
14
Amphenol
APH
$214B
| $5.33M | 4.31% |
279,860
+24,860
| +10% | +$470K |
2021 Q4
4 quarters
|
|
|
SYNH
15
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $4.22M | 3.42% |
115,018
+17,275
| +18% | +$683K |
2021 Q4
4 quarters
|
|
16
Barrett Business Services
BBSI
$766M
| $4.09M | 3.31% |
175,552
-32,000
| -15% | -$725K |
2021 Q4
4 quarters
|
|
17
Insperity
NSP
$1.86B
| $3.97M | 3.21% |
34,905
+2,130
| +6% | +$241K |
2021 Q4
4 quarters
|
|
|
18
Lindsay Corp
LNN
$1.15B
| $3.91M | 3.16% |
24,008
-9,924
| -29% | -$1.64M |
2021 Q4
4 quarters
|
|
19
HEICO Corp
HEI
$41.6B
| $3.91M | 3.16% |
25,433
+1,490
| +6% | +$232K |
2021 Q4
4 quarters
|
|
|
20
Resources Connection
RGP
$98.2M
| $3.45M | 2.79% |
187,485
-41,200
| -18% | -$757K |
2021 Q4
4 quarters
|
|
|
21
HEICO Corp Class A
HEI.A
$31.1B
| $2.74M | 2.21% |
22,830
+2,680
| +13% | +$327K |
2021 Q4
4 quarters
|
|
|
22
Maravai LifeSciences
MRVI
$1.11B
| $2.6M | 2.1% |
+181,500
| New | +$2.86M |
2022 Q4
0 quarters
|
|
|
IAA
23
DELISTED
IAA, Inc. Common Stock
IAA
| $2.19M | 1.77% |
54,784
-90,841
| -62% | -$3.43M |
2021 Q4
4 quarters
|
|
24
NRC Health Common Stock
NRC
$448M
| $1.32M | 1.07% |
35,358
-18,558
| -34% | -$718K |
2021 Q4
4 quarters
|
|
25
Trex
TREX
$4.55B
| $804K | 0.65% |
+19,000
| New | +$862K |
2022 Q4
0 quarters
|
|
Similar funds
ELM
FWS
CL
AFR
YAG
N
BCM
PHIMC
Alpine Peaks Capital's Q4 2022 Portfolio in Review
As of Q4 2022, Alpine Peaks Capital held 25 positions worth $124M, up 11% from $111M the previous quarter. Its ten largest holdings account for 55% of the portfolio.
Alpine Peaks Capital's Q4 2022 filing shows 2 new, 13 increased and 10 reduced positions. Its largest new stake was Maravai LifeSciences: 181,500 shares worth $2.6M. The largest sale was IAA, Inc. Common Stock, an estimated $3.43M.
By sector, the portfolio is most concentrated in Industrials at 29% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.
- Alpine Peaks Capital's largest Q4 2022 buy was Maravai LifeSciences: 181,500 shares worth $2.6M.
- Alpine Peaks Capital added most to Evertec in Q4 2022, an estimated $1.64M increase.
- Alpine Peaks Capital's biggest Q4 2022 reduction was IAA, Inc. Common Stock, cutting an estimated $3.43M.
- Alpine Peaks Capital's ten largest holdings make up 55% of its $124M portfolio in Q4 2022.
- Alpine Peaks Capital opened 2 new positions and closed 0 in Q4 2022.
- Alpine Peaks Capital's portfolio value rose 11% quarter-over-quarter to $124M.
Based on Alpine Peaks Capital's 13F filing for Q4 2022, filed 14 Feb 2023.